• “U.S. prevalence of inflammatory bowel disease (IBD) is estimated between 2.4 and 3.1 million, with differing burden across groups.
• IBD prevalence and health care costs are rising.
• In 2018, the total annual U.S. health care costs for IBD were about $8.5 billion.
• Biologic prescription drugs have shifted the patterns of cost and service use.”

Cener for Disease Control and Prevention – CDC (IBD Facts and Stats | IBD | CDC)